These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1536945
1. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta. Hannocks MJ, Oliver L, Gabrilove JL, Wilson EL. Blood; 1992 Mar 01; 79(5):1178-84. PubMed ID: 1536945 [Abstract] [Full Text] [Related]
2. Regulation of plasminogen activator and plasminogen activator inhibitor production by growth factors and cytokines in rat calvarial cells. Cheng SL, Shen V, Peck WA. Calcif Tissue Int; 1991 Nov 01; 49(5):321-7. PubMed ID: 1723649 [Abstract] [Full Text] [Related]
3. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. Allan EH, Zeheb R, Gelehrter TD, Heaton JH, Fukumoto S, Yee JA, Martin TJ. J Cell Physiol; 1991 Oct 01; 149(1):34-43. PubMed ID: 1834680 [Abstract] [Full Text] [Related]
4. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO. Invest Ophthalmol Vis Sci; 2002 Aug 01; 43(8):2799-805. PubMed ID: 12147618 [Abstract] [Full Text] [Related]
5. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. J Cell Biol; 1992 Aug 01; 118(4):901-9. PubMed ID: 1380001 [Abstract] [Full Text] [Related]
6. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1. Keski-Oja J, Koli K. J Invest Dermatol; 1992 Aug 01; 99(2):193-200. PubMed ID: 1629632 [Abstract] [Full Text] [Related]
7. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts. Xiao Y, Bunn CL, Bartold PM. J Periodontal Res; 1998 Jan 01; 33(1):17-26. PubMed ID: 9524317 [Abstract] [Full Text] [Related]
8. Cytokine modulation of plasminogen activator inhibitor-1 (PAI-1) production by human articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-B basic fibroblast growth factor. Campbell IK, Wojta J, Novak U, Hamilton JA. Biochim Biophys Acta; 1994 Jul 18; 1226(3):277-85. PubMed ID: 8054359 [Abstract] [Full Text] [Related]
9. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. van Hinsbergh VW, van den Berg EA, Fiers W, Dooijewaard G. Blood; 1990 May 15; 75(10):1991-8. PubMed ID: 2140060 [Abstract] [Full Text] [Related]
10. Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells. Iwamoto T, Nakashima Y, Sueishi K. Kidney Int; 1990 Jun 15; 37(6):1466-76. PubMed ID: 2113968 [Abstract] [Full Text] [Related]
11. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. Michel JB, Quertermous T. J Immunol; 1989 Aug 01; 143(3):890-5. PubMed ID: 2501387 [Abstract] [Full Text] [Related]
12. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells. Tienari J, Alanko T, Lehtonen E, Saksela O. Cell Regul; 1991 Apr 01; 2(4):285-97. PubMed ID: 1905574 [Abstract] [Full Text] [Related]
13. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. Macfelda K, Weiss TW, Kaun C, Breuss JM, Zorn G, Oberndorfer U, Voegele-Kadletz M, Huber-Beckmann R, Ullrich R, Binder BR, Losert UM, Maurer G, Pacher R, Huber K, Wojta J. J Mol Cell Cardiol; 2002 Dec 01; 34(12):1681-91. PubMed ID: 12505065 [Abstract] [Full Text] [Related]
17. Interleukin-1-mediated regulation of plasminogen activation in pregnant mare serum gonadotropin-primed rat granulosa cells is independent of prostaglandin production. Hurwitz A, Finci-Yeheskel Z, Dushnik M, Milwidsky A, Shimonovitz S, Yagel S, Adashi EY, Mayer M. J Soc Gynecol Investig; 1995 Apr 01; 2(5):691-9. PubMed ID: 9420877 [Abstract] [Full Text] [Related]
18. Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells. Wilson HM, Haites NE, Booth NA. Exp Nephrol; 1997 Apr 01; 5(3):233-8. PubMed ID: 9208283 [Abstract] [Full Text] [Related]
19. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. de Bart AC, Quax PH, Löwik CW, Verheijen JH. J Bone Miner Res; 1995 Sep 01; 10(9):1374-84. PubMed ID: 7502710 [Abstract] [Full Text] [Related]
20. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts. Hamilton JA, Piccoli DS, Leizer T, Butler DM, Croatto M, Royston AK. Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7180-4. PubMed ID: 1908092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]